Redeye: Speqta - Rahalaitos Makes its Mark

Redeye reiterates its positive view on Speqta as the first quarter was in line with our expectations. The acquisition of Rahalaitos substantially increases the group´s sales and earnings. The Corona Crisis is, on the other hand, challenging for Speqta with lower demand for loans, in the short-term, as the main effect. However, it does not change our positive long-term view of the company´s growth potential, and we continue to see a substantial upside potential in the stock.

Read more and download the research update: https://bit.ly/2WZrHxI

Start following companies at Redeye to recieve the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/